The study aimed to examine the varying experiences of children and caregivers in the United States during coronavirus disease 2019.
Valneva adjusts 2023 financial guidance after priority voucher sale delay – Pharmaceutical Technology
Share this article The secondary market for priority review vouchers currently sits at around $100m. Image credit: Shutterstock/mundissima. Valneva has adjusted its financial guidance for